Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	949,378	869,777	176,537	-	-	-
Market Cap Growth	528.10%	392.69%	-	-	-	-
Enterprise Value	896,768	816,363	152,373	-	-	-
Last Close Price	21150.00	19550.00	4085.00	-	-	-
PE Ratio	60.15	55.11	-	-	-	-
PS Ratio	17.78	16.29	11.90	-	-	-
PB Ratio	13.18	12.07	3.15	-	-	-
P/TBV Ratio	13.18	12.07	3.15	-	-	-
P/FCF Ratio	85.59	78.41	-	-	-	-
P/OCF Ratio	83.31	76.33	-	-	-	-
EV/Sales Ratio	16.80	15.29	10.27	-	-	-
EV/EBITDA Ratio	68.21	62.09	-	-	-	-
EV/EBIT Ratio	71.06	64.69	-	-	-	-
EV/FCF Ratio	80.85	73.60	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	-0.72	0.00	-0.02
Debt / EBITDA Ratio	0.01	0.01	-	5.26	-	-
Debt / FCF Ratio	0.01	0.01	-	4.74	-	-
Net Debt / Equity Ratio	-0.73	-0.73	-0.76	0.81	1.24	2.34
Net Debt / EBITDA Ratio	-4.00	-4.00	9.82	-6.28	1.85	2.25
Net Debt / FCF Ratio	-4.74	-4.74	5.35	-5.34	1.56	2.11
Asset Turnover	0.78	0.78	0.30	0.62	0.00	-
Quick Ratio	17.48	17.48	10.61	0.54	1.06	36.08
Current Ratio	17.62	17.62	10.94	0.54	1.06	36.10
Return on Equity (ROE)	24.65%	24.65%	-44.55%	-	-	-
Return on Assets (ROA)	11.55%	11.55%	-6.09%	4.07%	-36.85%	-
Return on Capital Employed (ROCE)	17.50%	17.50%	-8.50%	-11.50%	-343.70%	-44.10%
Earnings Yield	1.66%	1.81%	-4.58%	-	-	-
FCF Yield	1.17%	1.27%	-4.52%	-	-	-
Buyback Yield / Dilution	-	-	-41.46%	0.00%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.